Clinical Trials
COVALENT-101
A phase 1 clinical trial for patients with relapsed or refractory AML, ALL, DLBCL, MM or CLL/SLL.
–
–
COVALENT-102
A phase 1/1b clinical trial for patients with KRAS mutant, unresectable, locally advanced/metastatic NSCLC, PDAC, and CRC.
–
COVALENT-111
A phase 1/2 clinical trial in healthy adults and adults with Type 2 diabetes.
–
–
–